LCN2 and cancer: Several studies have shown that serum NGAL concentrations were higher in cancer patients compared with benign diagnoses or healthy controls, and that serum NGAL correlated with T staging, maximal tumor size, and lymph node involvement [[47], [48], [49], [50]].